Security key
09075V102
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)
CUSIP: 09075V102
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
- Shares outstanding
- 253,647,595
- Total 13F shares
- 47,396,816
- Share change
- -620,637
- Total reported value
- $4,209,911,815
- Put/Call ratio
- 227%
- Price per share
- $88.88
- Number of holders
- 268
- Value change
- -$68,924,940
- Number of buys
- 130
- Number of sells
- 122
Report period
Q1 2026
Institutions
268
Top holders
10
BNTX full security history
Previous quarter: Q4 2025
BioNTech SE SEC filings
BioNTech SE company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075V102
Recent filing periods:
Top shareholders of BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ATHOS KG |
13D/G
|
— |
40%
|
101,702,378
|
$9,712,577,099 | $0 | 31 Mar 2026 | |
| Medine GmbH |
13D/G
|
Prof. Ugur Sahin, M.D. |
18%
|
42,178,034
|
$4,386,515,536 | $0 | 31 Mar 2025 | |
| Ugur Sahin |
13D/G
3/4/5
|
Chief Executive Officer, 10%+ Owner |
16%
|
40,076,320
|
$3,827,288,560 | $0 | 31 Mar 2026 | |
| FMR LLC |
13F
|
Company |
2.3%
|
5,933,594
|
$564,878,131 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.8%
|
4,484,599
|
$426,934,000 | — | 31 Dec 2025 | |
| Se Flossbach von Storch |
13F
|
Individual |
1.7%
|
4,196,048
|
$399,463,770 | — | 31 Dec 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.5%
|
3,800,011
|
$361,761,047 | — | 31 Dec 2025 | |
| DODGE & COX |
13F
|
Company |
1.4%
|
3,614,491
|
$344,099,543 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.62%
|
1,578,094
|
$150,234,549 | — | 31 Dec 2025 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.59%
|
1,506,027
|
$143,373,770 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.54%
|
1,361,221
|
$129,588,239 | — | 31 Dec 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.49%
|
1,244,867
|
$118,511,339 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.45%
|
1,152,884
|
$109,754,540 | — | 31 Dec 2025 | |
| Capital International Investors |
13F
|
Company |
0.45%
|
1,134,941
|
$108,046,383 | — | 31 Dec 2025 | |
| GSK plc |
13F
|
Company |
0.35%
|
889,824
|
$84,711,245 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.29%
|
736,597
|
$70,124,035 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.27%
|
680,669
|
$64,799,832 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
678,175
|
$64,562,260 | — | 31 Dec 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.24%
|
604,916
|
$57,590,455 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.23%
|
577,900
|
$55,015,819 | — | 31 Dec 2025 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
0.2%
|
507,655
|
$48,328,756 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.19%
|
488,552
|
$46,510,150 | — | 31 Dec 2025 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.19%
|
481,397
|
$46,397,000 | — | 31 Dec 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.19%
|
470,000
|
$44,744,000 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.18%
|
446,283
|
$42,486,142 | — | 31 Dec 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
437,565
|
$41,656,188 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.16%
|
400,593
|
$38,136,454 | — | 31 Dec 2025 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.16%
|
400,382
|
$38,093,046 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.15%
|
388,867
|
$37,020,138 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.15%
|
375,000
|
$35,700,000 | — | 31 Dec 2025 | |
| Davern Capital Partners, LP |
13F
|
Company |
0.15%
|
371,216
|
$35,339,763 | — | 31 Dec 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.15%
|
368,923
|
$35,121,470 | — | 31 Dec 2025 | |
| LBP AM SA |
13F
|
Company |
0.15%
|
368,584
|
$35,089,197 | — | 31 Dec 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.14%
|
365,333
|
$34,780,000 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.13%
|
321,111
|
$30,636,396 | — | 31 Dec 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.11%
|
281,830
|
$26,830,216 | — | 31 Dec 2025 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.11%
|
273,073
|
$25,996,550 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.11%
|
272,365
|
$25,929,148 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.1%
|
260,107
|
$24,765,961 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.1%
|
256,225
|
$24,392,621 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.1%
|
250,331
|
$23,831,511 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
249,045
|
$23,709,084 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
241,573
|
$22,997,750 | — | 31 Dec 2025 | |
| CenterBook Partners LP |
13F
|
Company |
0.09%
|
236,175
|
$22,483,860 | — | 31 Dec 2025 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
0.09%
|
221,529
|
$21,090,000 | — | 31 Dec 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.08%
|
197,500
|
$18,802,000 | — | 31 Dec 2025 | |
| Asset Managment Groupama |
13F
|
Individual |
0.07%
|
189,069
|
$17,999,369 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
173,089
|
$16,478,074 | — | 31 Dec 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
169,178
|
$16,110,725 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.06%
|
160,464
|
$15,276,173 | — | 31 Dec 2025 |
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q1 2026
As of 31 Mar 2026,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
268 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,396,816 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., FMR LLC, PRIMECAP MANAGEMENT CO/CA/, FLOSSBACH VON STORCH SE, Dodge & Cox, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, Temasek Holdings (Private) Ltd, CITADEL ADVISORS LLC, and BANK OF AMERICA CORP /DE/.
This page lists
268
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
283
Q1 2026 holders
268
Holder diff
-15
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.